Want to see NAMS full AI Analyst Report?

NewAmsterdam Pharma Company (NAMS) Revenue

279 Followers

NewAmsterdam Pharma Company Revenue

NewAmsterdam Pharma Company had a revenue of 3.70M in the quarter ending Jun 30, 2026, with 21.74%. This bring the company's revenue in the last twelve months to 7.12M, Increased -68.44%. In the fiscal year ending Dec 31, 2025, NewAmsterdam Pharma Company had annual revenue of 22.50M with -50.61% growth.

Revenue (ttm)

7.12M

Revenue Growth

-88.87%

P/S Ratio

126.48

Revenue/Employee

$225,030

Employees

100

Market Cap

$2.85B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	22.50M	-23.06M	-50.61%
Dec 31, 2024	45.56M	31.47M	+223.37%
Dec 31, 2023	14.09M	-88.60M	-86.28%
Mar 31, 2023	102.69M	―	+∞%
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―